Edwards Lifesciences engages in the R&D and physical manufacturing of structural heart medical devices. The core product is artificial heart valve systems primarily aimed at transcatheter aortic valve replacement (TAVR). The company precision-processes medical-grade animal tissue and metal stents, assembling them into physical devices implantable in the human body. The strictly sterilized medical consumables are bulk-delivered to global heart specialty hospitals and surgical centers.